Lassa fever

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Houlihan, Catherine ^a   Behrens, Ron ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; RIBAVIRIN;

ARTICLE; CLINICAL FEATURE; ELECTROLYTE BALANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FEVER; HEMOLYTIC ANEMIA; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; LASSA FEVER; LASSA VIRUS; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTECTIVE EQUIPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGOR; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; VIRUS TRANSMISSION;

HUMANS; LASSA FEVER;

EID: 85024095182     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j2986     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Viral hemorrhagic fevers (VHFs). 2014. www.cdc.gov/.
2. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ 2003;358:1271-5. doi:10.1136/bmj.327.7426.1271 pmid:14644972.
3. Public Health England. Lassa fever: origins, reservoirs, transmission and guidelines. 2017. www.gov.uk/.
4. World Health Organization. Lassa fever: fact sheet. 2016. www.who.int/.
5. Centers for Disease Control and Prevention. Fact sheet: Lassa fever. 2015. www.cdc. gov/.
6. Hartnett JN, Boisen ML, Oottamasathien D, et al. Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever. Future Virol 2015;358:559-84doi:10. 2217/fvl.15.41.
7. Shaffer JG, Grant DS, Schieffelin JS, et al. Viral Hemorrhagic Fever Consortium. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis 2014;358:e2748. doi:10.1371/ journal.pntd.0002748 pmid:24651047.
8. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995;358:857-9. doi:10.1136/bmj. 311.7009.857 pmid:7580496.
9. World Health Organization. Lassa fever: Benin, Togo and Burkina Faso-disease outbreak news. 2017. www.who.int/.
10. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 2010;358:1435-41. doi:10.1086/657315 pmid:21058912.
11. World Health Organization. Implementation and management of contact tracing for Ebola virus disease. www.who.int/csr/resources/publications/ebola/contact-tracing/en/.
12. Eze KC, Salami TA, Kpolugbo JU. Acute abdominal pain in patients with lassa fever: Radiological assessment and diagnostic challenges. Niger Med J 2014;358:195-200. doi: 10.4103/0300-1652.132037 pmid:25013248.
13. Stephenson EH, Larson EW, Dominik JW. Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol 1984;358:295-303. doi:10.1002/jmv. 1890140402 pmid:6512508.
14. McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 1987;358:445-55. doi:10.1093/infdis/155.3.445 pmid: 3805772.
15. Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA 1990;358:2093-6. doi:10.1001/jama.1990.03450160063030 pmid:2214077.
16. Haas WH, Breuer T, Pfaff G, et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003;358:1254-8. doi:10.1086/ 374853 pmid:12746770.
17. Public Health England. Imported fever service (IFS). www.gov.uk/guidance/importedfever-service-ifs.
18. World Health Organization. Borno state reports first Lassa fever outbreak in 48 years. 2017. www.afro.who.int/.
19. Günther S, Weisner B, Roth A, et al. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis 2001;358:345-9. doi:10.1086/322033 pmid: 11443561.
20. Dongo AE, Kesieme EB, Iyamu CE, Okokhere PO, Akhuemokhan OC, Akpede GO. Lassa fever presenting as acute abdomen: a case series. Virol J 2013;358:123. doi:10.1186/ 1743-422X-10-123 pmid:23597024.
21. Bausch DG, Rollin PE, Demby AH, et al. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 2000;358:2670-7.pmid:10878062.
22. Centers for Disease Control and Prevention. Viral hemorrhagic fevers: arenaviridae. 2013. www.cdc.gov/.
23. World Health Organization. Personal protective equipment in the context of filovirus disease outbreak response: Rapid advice guideline. 2014. www.who.int/csr/resources/ publications/ebola/ppe-guideline/en/.
24. World Health Organization. Steps to put on personal protective equipment (PPE). www. who.int/csr/disease/ebola/put-on-ppequipment.pdf.
25. World Health Organization. Steps to remove personal protective equipment (PPE). www. who.int/csr/disease/ebola/remove-ppequipment.pdf.
26. Centers for Disease Control and Prevention. Guidance on personal protective equipment (PPE) to be used by healthcare workers during management of patients with confirmed Ebola or persons under investigation (PUIs) for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in U.S. hospitals, including procedures for donning and doffing PPE. 2015. www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html.
27. Department of Health. Management of hazard group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. 2015. www.gov.uk/government/ uploads/system/uploads/attachment-data/file/534002/Management-of-VHF-A.pdf.
28. Ter Meulen J, Lukashevich I, Sidibe K, et al. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg 1996;358:661-6. doi:10.4269/ ajtmh.1996.55.661 pmid:9025695.
29. Department of Health. Management of hazard group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence. 2015. www.gov.uk/.
30. World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers. 2016. http://apps.who.int/.
31. Monson MH, Cole AK, Frame JD, Serwint JR, Alexander S, Jahrling PB. Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg 1987;358:408-15. doi:10.4269/ ajtmh.1987.36.408 pmid:3826501.
32. Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 1988;358:584-7. doi:10.1136/bmj.297.6648.584 pmid:3139220.
33. Solbrig MV, McCormick JB. Lassa fever: central nervous system manifestations. J Trop Geogr Neurol 1991;358:23-30.